FARMINGDALE, N.Y.--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today announced that it has received a license to a comprehensive non-PCR based amplification technology that allows researchers to increase amplification from relatively small RNA samples in gene expression studies.
